T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$3.15B |
| 2 |
Global Payments
GPN
|
+$2B |
| 3 |
NextEra Energy
NEE
|
+$1.82B |
| 4 |
Salesforce
CRM
|
+$1.51B |
| 5 |
Boeing
BA
|
+$1.38B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WP
Worldpay, Inc.
WP
|
+$3.23B |
| 2 |
DATA
Tableau Software, Inc.
DATA
|
+$1.76B |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$1.49B |
| 4 |
Bank of America
BAC
|
+$1.43B |
| 5 |
Elevance Health
ELV
|
+$1.39B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 15.83% |
| 3 | Financials | 13.92% |
| 4 | Consumer Discretionary | 13.43% |
| 5 | Industrials | 10.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Wayfair
W
$13.9B
| $7.49M | ﹤0.01% |
66,825
+1,822
| +3% | +$233K |
|
|
KRTX
1327
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $7.47M | ﹤0.01% |
457,981
+4,607
| +1% | +$89.5K |
|
|
AXON
1328
Axon Enterprise
AXON
$48.7B
| $7.37M | ﹤0.01% |
129,709
-3,524
| -3% | -$222K |
|
1329
eHealth
EHTH
$39.7M
| $7.36M | ﹤0.01% |
110,172
+683
| +0.6% | +$61.6K |
|
1330
Cooper-Standard Automotive
CPS
$490M
| $7.35M | ﹤0.01% |
179,763
-59,404
| -25% | -$2.49M |
|
1331
Cheniere Energy
LNG
$55.4B
| $7.27M | ﹤0.01% |
115,268
+3,397
| +3% | +$218K |
|
|
ESTE
1332
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $7.14M | ﹤0.01% |
2,195,634
-260,621
| -11% | -$1.11M |
|
1333
Rigel Pharmaceuticals
RIGL
$782M
| $7.13M | ﹤0.01% |
381,470
-128,153
| -25% | -$2.65M |
|
1334
ManpowerGroup
MAN
$2.61B
| $7.09M | ﹤0.01% |
84,127
-3,187
| -4% | -$278K |
|
1335
Standex International
SXI
$4B
| $7.04M | ﹤0.01% |
96,457
-18,742
| -16% | -$1.3M |
|
1336
Under Armour Class C
UA
$2.2B
| $7.03M | ﹤0.01% |
387,964
+210
| +0.1% | +$4.14K |
|
|
CCI.PRA
1337
DELISTED
Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A
CCI.PRA
| $6.98M | ﹤0.01% |
5,515
-1,175
| -18% | -$1.47M |
|
1338
Toll Brothers
TOL
$13.9B
| $6.97M | ﹤0.01% |
169,690
+439
| +0.3% | +$16.2K |
|
1339
Coty
COTY
$2.43B
| $6.94M | ﹤0.01% |
660,684
-1,639,458
| -71% | -$17M |
|
|
AERI
1340
DELISTED
Aerie Pharmaceuticals
AERI
| $6.94M | ﹤0.01% |
361,167
-3,876
| -1% | -$88.8K |
|
|
FOLD
1341
DELISTED
Amicus Therapeutics
FOLD
| $6.89M | ﹤0.01% |
859,777
-4,804
| -0.6% | -$52.1K |
|
1342
Annaly Capital Management
NLY
$17.4B
| $6.82M | ﹤0.01% |
193,630
+11,829
| +7% | +$426K |
|
1343
RB Global
RBA
$16B
| $6.76M | ﹤0.01% |
169,363
-5,548
| -3% | -$206K |
|
1344
Denali Therapeutics
DNLI
$4.04B
| $6.74M | ﹤0.01% |
440,197
-40,943
| -9% | -$782K |
|
1345
Comfort Systems
FIX
$61.2B
| $6.72M | ﹤0.01% |
152,057
+131,357
| +635% | +$5.73M |
|
1346
Inogen
INGN
$154M
| $6.6M | ﹤0.01% |
137,841
-1,306
| -0.9% | -$68.1K |
|
1347
EverQuote
EVER
$867M
| $6.53M | ﹤0.01% |
306,102
+12,684
| +4% | +$240K |
|
1348
Under Armour
UAA
$2.3B
| $6.47M | ﹤0.01% |
324,738
+965
| +0.3% | +$21.3K |
|
1349
Meritage Homes
MTH
$4.75B
| $6.46M | ﹤0.01% |
183,702
+296
| +0.2% | +$9.24K |
|
1350
TripAdvisor
TRIP
$1.26B
| $6.43M | ﹤0.01% |
166,194
+599
| +0.4% | +$25K |
|
Similar funds
T. Rowe Price Associates's Q3 2019 Portfolio in Review
As of Q3 2019, T. Rowe Price Associates held 2,592 positions worth $706B, down 0.8% from $712B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Trading was light in Q3 2019: portfolio turnover was 4.9%. T. Rowe Price Associates opened 52 new positions and exited 74, leaving the 2,592-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2019 buy was The Southern Company: 9,440,159 shares worth $502M.
- T. Rowe Price Associates added most to Fidelity National Information Services in Q3 2019, an estimated $3.15B increase.
- T. Rowe Price Associates's biggest Q3 2019 reduction was Bank of America, cutting an estimated $1.43B.
- T. Rowe Price Associates fully exited Worldpay, Inc. in Q3 2019, selling an estimated $3.23B.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $706B portfolio in Q3 2019.
- T. Rowe Price Associates opened 52 new positions and closed 74 in Q3 2019.
- T. Rowe Price Associates's portfolio value fell 0.8% quarter-over-quarter to $706B.
Based on T. Rowe Price Associates's 13F filing for Q3 2019, filed 14 Nov 2019.